The Big Pharma Alternative or BPA
The BigPharma model of MS drug development is broken; it is too expensive, takes too long and ignores potentially effective therapies that are off patent. Is there an alternative to BigPharma? We are not sure but would like to explore whether or not there is political will to make the necessary changes. We need a new regulatory framework to incentivise academic or non-profit MS drug development. If you are interested please register an expression of interest. Please note that the data we collect as part of the registration will not be used for any other purpose and will not be given to a third party.